Sinopep-Allsino
688076.SSSinopep-Allsino Bio Pharmaceutical Co.,Ltd. Price (688076.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
214,389,612
(0.5656)%Revenue and Profitability
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 8,777,246 | 8,022,583 | 228,867,458 | 255,527,351 | 371,530,570 | 566,872,462 | 643,869,464 | 651,291,707 | 1,026,346,449 |
| Net Income | -13,635,904 | -25,157,145 | -30,153,958 | -74,797,496 | 41,929,337 | 43,908,449 | 48,610,494 | 123,441,585 | 115,388,354 | 129,106,565 | 162,936,105 |
| FCF USD | 19,042,532 | 58,487,840 | -124,695,839 | -33,090,338 | -62,229,103 | -101,426,589 | -230,251,868 | 30,097,796 | -52,609,750 | -409,070,441 | -310,425,313 |
| OCF USD | 43,671,707 | 68,176,754 | -112,624,909 | -21,951,560 | 11,110,070 | 96,057,443 | 46,135,933 | 141,381,334 | 180,746,199 | 29,292,086 | 350,213,814 |
Financial Health - DEBT
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.16 | 1.21 | 0.32 | 0.03 | 0.00 | 1.86 |
| D/E | 26.33 | -1.77 | 0.98 | 3.03 | 0.41 | 0.11 | 0.24 | 0.26 | 0.05 | 0.17 | 0.39 |
| CA/CL | 0.08 | 0.03 | 0.41 | 0.17 | 0.64 | 1.43 | 0.88 | 1.28 | 4.01 | 1.91 | 1.54 |
| TA/TL | 1.02 | 0.88 | 1.59 | 1.28 | 2.11 | 3.96 | 3.07 | 3.25 | 6.69 | 4.22 | 2.61 |
| Total Debt | 97,030,000 | 38,000,000 | 71,700,000 | 105,936,340 | 132,478,248 | 88,867,440 | 200,587,864 | 251,720,560 | 83,649,538 | 320,190,908 | 849,693,121 |
Management Performance
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | -17.30% | -188.98% | -24.67% | -50.23% | 9.05% | 5.02% | 5.38% | 9.89% | 5.76% | 5.43% | 5.81% |
| ROE | -370.00% | 117.16% | -41.13% | -213.99% | 13.05% | 5.64% | 5.83% | 12.81% | 6.37% | 6.76% | 7.51% |
| ROA | 0.00% | -16.60% | -15.33% | -46.72% | 6.86% | 4.25% | 3.60% | 8.60% | 5.12% | 4.87% | 4.59% |
| NM % | - | - | -343.55% | -932.34% | 18.32% | 17.18% | 13.08% | 21.78% | 17.92% | 19.82% | 15.88% |
| FCF / R% | 0.00% | 0.00% | -1,420.67% | -412.46% | -27.19% | -39.69% | -61.97% | 5.31% | -8.17% | -62.81% | -30.25% |
| FCF / NI% | -139.65% | -232.49% | 413.53% | 44.24% | -148.41% | -227.00% | -513.89% | 25.08% | -48.35% | -333.20% | -190.52% |
| Operating Margin (OM) | - | - | -1.28 | -11.90 | -0.23 | -0.04 | 0.10 | 0.28 | 0.41 | 0.55 | 0.45 |
Per Share
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | -0.27 | -0.50 | -0.60 | -0.35 | 0.37 | 0.32 | 0.23 | 0.58 | 0.54 | 0.61 | 0.76 |
| SPS | 0.00 | 0.00 | 0.17 | 0.04 | 2.02 | 1.86 | 1.74 | 2.66 | 3.02 | 3.06 | 4.79 |
| OCPS | 0.86 | 1.36 | -2.24 | -0.10 | 0.10 | 0.70 | 0.22 | 0.66 | 0.85 | 0.14 | 1.63 |
| FCPS | 0.38 | 1.16 | -2.48 | -0.16 | -0.55 | -0.74 | -1.08 | 0.14 | -0.25 | -1.92 | -1.45 |
| BVPS | 0.07 | -0.43 | 1.46 | 0.16 | 2.83 | 5.72 | 3.94 | 4.53 | 8.48 | 9.03 | 10.21 |
Per Share - CAGR
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | -0.27 | -0.50 | -0.60 | -0.35 | 0.37 | 0.32 | 0.23 | 0.58 | 0.54 | 0.61 | 0.76 |
| CAGR-SPS | 0.00 | 0.00 | 0.17 | 0.04 | 2.02 | 1.86 | 1.74 | 2.66 | 3.02 | 3.06 | 4.79 |
| CAGR-OCPS | 0.86 | 1.36 | -2.24 | -0.10 | 0.10 | 0.70 | 0.22 | 0.66 | 0.85 | 0.14 | 1.63 |
| CAGR-FCPS | 0.38 | 1.16 | -2.48 | -0.16 | -0.55 | -0.74 | -1.08 | 0.14 | -0.25 | -1.92 | -1.45 |
| CAGR-BVPS | 0.07 | -0.43 | 1.46 | 0.16 | 2.83 | 5.72 | 3.94 | 4.53 | 8.48 | 9.03 | 10.21 |